Economic analysis of rapid multiplex polymerase chain reaction testing for meningitis/encephalitis in pediatric

Steve Duff1, Rodrigo Hasbun2, Christine C Ginocchio3,4,5

  • 1Veritas Health Economics Consulting, Carlsbad, CA, USA.

Future Microbiology
|January 11, 2018
PubMed

Insights

Rapid syndromic testing for pediatric meningitis/encephalitis is cost-effective. Testing all suspected cases with FilmArray® (FA) offers greater economic benefits compared to standard care or targeted testing.

Area of Science:

  • Infectious Diseases
  • Health Economics
  • Pediatric Medicine

Background:

  • Community-acquired meningitis/encephalitis in children poses diagnostic challenges.
  • Standard diagnostic procedures can be time-consuming and costly.
  • Rapid diagnostic tools are needed to improve patient outcomes and resource allocation.

Purpose of the Study:

  • To evaluate the economic impact of a rapid syndromic testing strategy for pediatric patients with suspected meningitis/encephalitis.
  • To compare the costs of standard care (SOC) with FilmArray® (FA) testing strategies.

Main Methods:

  • A cost-effectiveness model was developed to simulate diagnosis and clinical decisions.
  • Two cerebrospinal fluid (CSF) testing strategies using FilmArray® (FA) were compared to SOC.
  • Resource utilization and associated costs were analyzed.

Main Results:

  • FilmArray® (FA) accurately diagnosed 97% of pathogens causing approximately 75% of cases.
  • Mean cost per case ranged from $17,599 to $22,025.
  • Syndromic testing of all suspected cases yielded greater savings ($3481/case) than targeted testing ($2157/case) or SOC.

Conclusions:

  • Syndromic testing using FilmArray® (FA) for all suspected pediatric meningitis/encephalitis cases is more cost-effective than SOC.
  • Targeted syndromic testing offers savings but less than universal syndromic testing.
  • Implementing rapid syndromic testing can lead to significant economic benefits in pediatric infectious disease diagnostics.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
281
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
256
Translesion DNA Polymerases02:10

Translesion DNA Polymerases

Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
11.3K
Bacterial RNA Polymerase00:43

Bacterial RNA Polymerase

Unlike eukaryotes, bacteria use a single RNA Polymerase (RNAP) to transcribe all genes. The different subunits of bacterial RNAPhave distinct functions. The multisubunit structure of the bacterial RNAP helps the enzyme to maintain catalytic function, facilitate assembly, interact with DNA and RNA, and self-regulate its activity.
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
32.9K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
318